Test Overview
Test Methodology

Next gen sequencing

Test Usage

FDA-approved tumor test that determines HRD status using BRCA status and Genomic Instability Status in patients with ovarian cancer

Reference Range *

Interpretive report provided

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Test Details
Days Set Up
Monday - Friday
Analytic Time

14 - 21 days

Soft Order Code
Reference Laboratory
Myriad Genetics
Special Testing
Specimen Requirements
Special Handling

There are test kits supplied by the company to be used for shipping the block/slides. Sendouts only has 1 in stock, please contact the company to order kits if needed.

Normal Volume
40 microns of tumor, at least 20% of tumor in the block chosen by a pathologist
Storage Temperature
Additional Information

Test performed by Myriad Genetics- Oncology